Arkolith/Insider Trading/PMCB/Form 4

Silverman Joshua

CEO and President, DirectorPharmaCyte Biotech, Inc. (PMCB) · full profile →Form 4 · filed Jan 7, 2026
Net Buying
Open-Market Buys
$80K
Open-Market Sells
$0
Net Open-Market Flow
$80K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 7, 2026Buy(P)40K$0.83$33K416K
Jan 6, 2026Buy(P)30K$0.79$24K376K
Jan 5, 2026Buy(P)30K$0.78$23K346K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-26-000148) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML